Comparison of demographic features and laboratory parameters between COVID-19 deceased patients and surviving severe and critically ill cases

被引:0
|
作者
Lei Wang [1 ]
Yang Gao [2 ]
Zhao-Jin Zhang [3 ]
Chang-Kun Pan [4 ]
Ying Wang [5 ]
Yu-Cheng Zhu [6 ]
Yan-Peng Qi [7 ]
Feng-Jie Xie [8 ]
Xue Du [1 ]
Na-Na Li [1 ]
Peng-Fei Chen [1 ]
Chuang-Shi Yue [1 ]
Ji-Han Wu [1 ]
Xin-Tong Wang [1 ]
Yu-Jia Tang [1 ]
Qi-Qi Lai [1 ]
Kai Kang [1 ]
机构
[1] Department of Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University
[2] Department of Critical Care Medicine, The Jiamusi Cancer Hospital
[3] Department of Critical Care Medicine, The Yichun Forestry Administration Central Hospital
[4] Department of Critical Care Medicine, The Hongqi Hospital Affiliated to Mudanjiang Medical University
[5] Department of Cardiology, The Hongxinglong Hospital of Beidahuang Group
[6] Department of Critical Care Medicine, The First People Hospital of Mudanjiang City
[7] Department of Critical Care Medicine, The Hongxinglong Hospital of Beidahuang Group
[8] Department of Critical Care Medicine, The Sixth Affiliated Hospital of Harbin Medical University
基金
中国国家自然科学基金;
关键词
D O I
暂无
中图分类号
R563.1 [肺炎];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Coronavirus disease 2019(COVID-19) has been far more devastating than expected, showing no signs of slowing down at present. Heilongjiang Province is the most northeastern province of China, and has cold weather for nearly half a year and an annual temperature difference of more than 60℃, which increases the underlying morbidity associated with pulmonary diseases, and thus leads to lung dysfunction. The demographic features and laboratory parameters of COVID-19 deceased patients in Heilongjiang Province, China with such climatic characteristics are still not clearly illustrated.AIM To illustrate the demographic features and laboratory parameters of COVID-19 deceased patients in Heilongjiang Province by comparing with those of surviving severe and critically ill cases.METHODS COVID-19 deceased patients from different hospitals in Heilongjiang Province were included in this retrospective study and compared their characteristics with those of surviving severe and critically ill cases in the COVID-19 treatment center of the First Affiliated Hospital of Harbin Medical University. The surviving patients were divided into severe group and critically ill group according to the Diagnosis and Treatment of New Coronavirus Pneumonia(the seventh edition).Demographic data were collected and recorded upon admission. Laboratory parameters were obtained from the medical records, and then compared among the groups.RESULTS Twelve COVID-19 deceased patients, 27 severe cases and 26 critically ill cases were enrolled in this retrospective study. No differences in age, gender, and number of comorbidities between groups were found. Neutrophil percentage(NEUT%), platelet(PLT), C-reactive protein(CRP), creatine kinase isoenzyme(CK-MB), serum troponin I(TNI) and brain natriuretic peptides(BNP) showed significant differences among the groups(P = 0.020, P = 0.001, P < 0.001, P = 0.001, P < 0.001, P <0.001, respectively). The increase of CRP, D-dimer and NEUT% levels, as well as the decrease of lymphocyte count(LYMPH) and PLT counts, showed significant correlation with death of COVID-19 patients(P = 0.023, P = 0.008, P = 0.045, P = 0.020, P = 0.015, respectively).CONCLUSION Compared with surviving severe and critically ill cases, no special demographic features of COVID-19 deceased patients were observed, while some laboratory parameters including NEUT%, PLT, CRP, CK-MB, TNI and BNP showed significant differences. COVID-19 deceased patients had higher CRP, D-dimer and NEUT% levels and lower LYMPH and PLT counts.
引用
收藏
页码:8161 / 8169
页数:9
相关论文
共 50 条
  • [31] Pneumomediastinum in COVID-19 critically ill patients
    Ben Braiek, D.
    Zorgati, H.
    Mighri, I.
    Brahmi, H.
    Ben Jazia, R.
    Kacem, A.
    Kharrat, I.
    Ayachi, J.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [32] Endotoxemia in Critically Ill Patients with COVID-19
    Khan, Sobia
    Bolotova, Olena
    Sahib, Haseena
    Foster, Debra
    Mallipattu, Sandeep K.
    BLOOD PURIFICATION, 2022, 51 (06) : 513 - 519
  • [33] Metoprolol in Critically Ill Patients With COVID-19
    Clemente-Moragon, Agustin
    Martinez-Milla, Juan
    Oliver, Eduardo
    Santos, Arnoldo
    Flandes, Javier
    Fernandez, Iker
    Rodriguez-Gonzalez, Lorena
    Serrano del Castillo, Cristina
    Ioan, Ana-Maria
    Lopez-Alvarez, Maria
    Gomez-Talavera, Sandra
    Galan-Arriola, Carlos
    Fuster, Valentin
    Perez-Calvo, Cesar
    Ibanez, Borja
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (10) : 1001 - 1011
  • [34] Simvastatin in Critically Ill Patients with Covid-19
    Hills, Thomas E.
    Lorenzi, Elizabeth
    Berry, Lindsay R.
    Shyamsundar, Murali
    Al-Beidh, Farah
    Annane, Djillali
    Arabi, Yaseen
    Aryal, Diptesh
    Au, Carly
    Beane, Abigail
    Bhimani, Zahra
    Bonten, Marc
    Bradbury, Charlotte A.
    Brunkhorst, Frank M.
    Burrell, Aidan
    Buxton, Meredith
    Calfee, Carolyn S.
    Cecconi, Maurizio
    Cheng, Allen C.
    Cove, Matthew E.
    Detry, Michelle A.
    Estcourt, Lise J.
    Fitzgerald, Mark
    Goligher, Ewan C.
    Goossens, Herman
    Green, Cameron
    Haniffa, Rashan
    Harrison, David A.
    Hashmi, Madiha
    Higgins, Alisa M.
    Huang, David T.
    Ichihara, Nao
    Jayakumar, Deva
    Kruger, Peter S.
    Lamontagne, Francois
    Lampro, Lamprini
    Lawler, Patrick R.
    Marshall, John C.
    Mason, Alexina J.
    McGlothlin, Anna
    McGuinness, Shay
    McQuilten, Zoe K.
    McVerry, Bryan J.
    Mouncey, Paul R.
    Murthy, Srinivas
    Neal, Matthew D.
    Nichol, Alistair D.
    O'Kane, Cecilia M.
    Parke, Rachael L.
    Parker, Jane C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (25): : 2341 - 2354
  • [35] Care for Critically Ill Patients With COVID-19
    Murthy, Srinivas
    Gomersall, Charles D.
    Fowler, Robert A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (15): : 1499 - 1500
  • [36] Proenkephalin in Critically Ill Patients with COVID-19
    Ostermann, Marlies
    Hartmann, Oliver
    Schulte, Janin
    D'Amato, Fabiola
    Vas, Kyma Morera
    Lorah, Shelley
    Radcliffe, Gillian
    Lumlertgul, Nuttha
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [37] Evaluation of coagulation function in critically ill patients with severe Covid-19 pneumonia
    Rodriguez Martin, I.
    Montenegro Martinez, J.
    Nunez Jurado, D.
    CLINICA CHIMICA ACTA, 2022, 530 : S185 - S185
  • [38] CLINICAL FEATURES AND OUTCOMES OF CRITICALLY ILL ELDERLY PATIENTS WITH COVID-19 INFECTION
    Mahdi, Ahmed
    Abouzid, Mahmoud
    Raru, Yonas
    Kumar, Anup
    Aguilar, Rodrigo
    Shweihat, Yousef
    Bandak, Ghassan
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 57 - 57
  • [39] Clinical features and risk factors of severely and critically ill patients with COVID-19
    Xin Chu
    Gui-Fang Zhang
    Yong-Ke Zheng
    Yi-Gang Zhong
    Li Wen
    Ping Zeng
    Chun-Yi Fu
    Xun-Liang Tong
    Yun-Fei Long
    Jing Li
    Ya-Lin Liu
    Zhi-Gang Chang
    Huan Xi
    World Journal of Clinical Cases, 2022, 10 (03) : 840 - 855
  • [40] COVID-19 is associated with distinct myopathic features in the diaphragm of critically ill patients
    Shi, Zhonghua
    Bogaards, Sylvia J. P.
    Conijn, Stefan
    Onderwater, Yeszamin
    Espinosa, Pedro
    Bink, Diewertje, I
    van den Berg, Marloes
    van de Locht, Martijn
    Bugiani, Marianna
    van der Hoeven, Hans
    Boon, Reinier A.
    Heunks, Leo
    Ottenheijm, Coen A. C.
    BMJ OPEN RESPIRATORY RESEARCH, 2021, 8 (01)